These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2739124

  • 1. [Efficacy and safety of long-term and low-dose desferrioxamine therapy against hyperaluminemia and the clinical symptoms associated with hyperaluminemia in patients undergoing maintenance hemodialysis].
    Kuramochi G.
    Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):267-73. PubMed ID: 2739124
    [Abstract] [Full Text] [Related]

  • 2. Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules.
    Barata JD, D'Haese PC, Pires C, Lamberts LV, Simões J, De Broe ME.
    Nephrol Dial Transplant; 1996 Jan; 11(1):125-32. PubMed ID: 8649620
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT, Milliner DS, Johnson WJ.
    Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
    [Abstract] [Full Text] [Related]

  • 4. Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients.
    Kan WC, Chien CC, Wu CC, Su SB, Hwang JC, Wang HY.
    Nephrol Dial Transplant; 2010 May; 25(5):1604-8. PubMed ID: 19948879
    [Abstract] [Full Text] [Related]

  • 5. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.
    D'Haese PC, Couttenye MM, Goodman WG, Lemoniatou E, Digenis P, Sotornik I, Fagalde A, Barsoum RS, Lamberts LV, De Broe ME.
    Nephrol Dial Transplant; 1995 Oct; 10(10):1874-84. PubMed ID: 8592597
    [Abstract] [Full Text] [Related]

  • 6. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 14; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D, Simícková J, Kubátko J, Syrovátka P.
    Cas Lek Cesk; 1989 Dec 15; 128(51):1611-4. PubMed ID: 2631999
    [Abstract] [Full Text] [Related]

  • 9. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.
    Seifert A, von Herrath D, Schaefer K.
    Q J Med; 1987 Dec 15; 65(248):1015-24. PubMed ID: 3455553
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N.
    Nihon Jinzo Gakkai Shi; 1991 Jun 15; 33(6):587-96. PubMed ID: 1920939
    [Abstract] [Full Text] [Related]

  • 11. [A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient].
    Yamagata K, Kobayashi M, Koyama A, Narita M, Amagai H, Ohno A, Yoshikawa S.
    Nihon Jinzo Gakkai Shi; 1991 Apr 15; 33(4):437-42. PubMed ID: 1875564
    [Abstract] [Full Text] [Related]

  • 12. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P, Day JP.
    Clin Nephrol; 1985 Apr 15; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [Abstract] [Full Text] [Related]

  • 13. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M, Sipilä R, Pitkänen E.
    Scand J Urol Nephrol Suppl; 1990 Apr 15; 131():49-54. PubMed ID: 2075470
    [Abstract] [Full Text] [Related]

  • 14. Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term results.
    Kovarik J, Irschik H, Graf H, Woloszczuk W, Meisinger V, Linkesch W, Stummvoll HK.
    Contrib Nephrol; 1985 Apr 15; 49():44-55. PubMed ID: 3830570
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG, Acuña Aguerre G, Fernández Martín JL, Mouzo R, Cannata Andía JB.
    Nephrol Dial Transplant; 1994 Apr 15; 9(10):1431-4. PubMed ID: 7816256
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.